Floatz logo

Edoxaban

Intracranial Hemorrhage, Hypertensive

University of EdinburghSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

40 Active assets in the Intracranial Hemorrhage, Hypertensive cohort.

Asset / SponsorPhaseRating
Edoxaban
Population Health Research Institute
Phase 4BBB
Tranexamic Acid
Christian Medical College and Hospital, Ludhiana, India
Phase 4BB
Acetylsalicylic Acid
University Hospital, Lille
Phase 4BB
Rivaroxaban
Imperial College London
Phase 3BB
Tenecteplase
Gaurav Gupta, MD
Phase 3BB

View all 50 →

Same molecule, other indications

Edoxaban is also rated in:

atrial fibrillationDormant
A
Indicative ·
83 / 100
View asset →
intracerebral hemorrhageDormant
BBB
Indicative ·
78 / 100
View asset →
EmbolismDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →